Celldex Therapeutics, Inc. Investments and Cash
Celldex Therapeutics, Inc. (CLDX) had Investments and Cash of $717.60 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets
us-gaap:InvestmentsAndCash · last filed 2026-08-06
- 2026-06-30: Investments and Cash $717.60M.
- 2026-03-31: Investments and Cash $451.50M.
- 2025-12-31: Investments and Cash $518.60M.
- 2025-09-30: Investments and Cash $583.20M.
| Period end | Investments and Cash |
|---|---|
| 2026-06-30 | $717.60M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $451.50M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $518.60M 10-K · filed 2026-02-25 |
| 2025-09-30 | $583.20M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $630.30M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $673.30M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $725.30M 10-K · filed 2025-02-27 |
| 2024-09-30 | $756.00M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $802.30M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $823.80M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $423.60M 10-K · filed 2024-02-26 |
| 2023-09-30 | $235.30M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $252.70M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $278.40M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $305.00M 10-K · filed 2023-02-28 |
| 2022-09-30 | $323.50M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $356.80M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $380.50M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $408.30M 10-K · filed 2022-02-28 |
| 2021-09-30 | $423.10M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $164.00M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $176.10M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $194.40M 10-K · filed 2021-03-29 |
| 2020-09-30 | $199.60M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $206.90M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $53.70M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $64.40M 10-K · filed 2020-03-26 |
| 2019-09-30 | $72.90M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $81.30M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $85.10M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $94.00M 10-K · filed 2019-03-07 |
| 2018-09-30 | $105.60M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $114.00M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $123.20M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $139.40M 10-K · filed 2018-03-07 |
| 2017-09-30 | $140.50M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $154.00M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $167.00M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $189.80M 10-K · filed 2017-03-14 |
| 2016-09-30 | $203.20M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $220.10M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $254.00M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $289.90M 10-K/A · filed 2016-02-25 |
| 2015-09-30 | $304.60M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $334.00M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $359.80M 10-Q · filed 2015-04-29 |
| 2014-12-31 | $201.00M 10-K · filed 2015-02-24 |
| 2014-09-30 | $224.10M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $252.40M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $274.20M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $303.00M 10-K · filed 2014-03-03 |
| 2013-09-30 | $136.60M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $155.00M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $182.40M 10-Q · filed 2013-05-03 |
| 2012-12-31 | $84.00M 10-K · filed 2013-03-08 |
| 2012-09-30 | $77.60M 10-Q · filed 2012-11-02 |
| 2012-06-30 | $78.70M 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |